This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

HealthStream's CEO Discusses F2Q12 Earnings Results - Earnings Call Transcript

Robert A. Frist, Jr.

We’ll start by highlighting a few financials and then turn to operational performance and then turn to your questions shortly thereafter. On a financial highlights standpoint consolidated revenues were up 23% to $25.8 million in the second quarter over the prior year same quarter while operating income was up a strong 30% to $4 million in the same time period. Net income was up 33% to $2.4 million in the second quarter over the prior year same quarter an adjusted EBITDA was strong at about $5.9 million in the second quarter which is up 27% over the prior year same quarter. Gerry Hayden, our CFO will go into greater detail on the financials after I do a bit of an operational performance overview.

The sales execution during the quarter was very strong. We added approximately 125,000 new subscribers that were contracted to use the learning platform during the quarter. This performance exceeds the range of our long standing and well stated quarterly goal of contacting 20,000 to 50,000 net new subscribers in a quarter so we congratulation the sales organization for bringing in a strong lift to the counts including [Parkman] Health & Hospital System which importantly also contracted for the HealthStream Competency Center. Sharp Healthcare a large integrated delivery network based in San Diego California, Good Samaritan Hospital Medical Center, Evergreen Healthcare and the Ohio State Health Network were among many others during the quarter, but clearly a strong operational performance from the sales organization this quarter.

We look forward to celebrating with all our employees as we crossover the three million contracted subscriber milestone in the future. The good news also is the sales execution was well supported by execution of our implementation teams. We implemented approximately 124,000 new subscribers that were added to the learning platform during the second quarter. We now have 2.78 million healthcare subscribers implemented. That’s an important milestone because we begin revenue recognition once contracted subscribers become implemented subscribers.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,678.23 -40.31 -0.23%
S&P 500 2,056.15 -4.90 -0.24%
NASDAQ 4,863.3620 -13.1570 -0.27%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs